Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Okay. Good morning, everyone. Thank you so much for joining us here at our Virtual Bank of America Health Care Conference. It is my pleasure. I'm Tazeen Ahmad, one of the SMID biotech analysts here at BofA. It's my pleasure to introduce our next presenting company, Alnylam.
Presenting for Alnylam this morning is Yvonne Greenstreet, Chief Operating Officer. Dr. Greenstreet has 25 years of global experience in the pharma industry, and she's had several senior roles in research and development as well as strategy and portfolio management. She successfully led product development and commercialization teams in a wide range of therapeutic areas. Dr. Greenstreet was previously Senior VP and Head of Medicine Development at Pfizer and a member of their executive team for the specialty business. She has a wide range of experiences in large companies and it is my pleasure to be speaking with you formally for the first time this morning, Dr. Greenstreet. Thanks for joining us.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
